Page results
-
Professor Lunn's specialist clinical and research interests are in the inflammatory neuropathies, particularly Guillain-Barré syndrome, CIDP and paraproteinaemic neuropathies.
-
For patients aged 13-18 we have a dedicated team covering a range of conditions, particularly specialising in reconstructive urology.
-
UCLH pharmacy provides pharmacy services across UCLH. We aim to provide safe, effective and economical use of medicines while supporting education, training and research.
-
Professor Hough is a consultant heamatologist at UCLH. She has specialist expertise in the management of acute lymphoblastic leukaemia in teenagers and young adults, and the use of umbilical cord blood as an alternative source of haemopoietic stem cells.
-
Patient information for patients suffering from long COVID who are returning to work.
-
Patient information for women who have chosen to have surgical management under general anaesthetic following a diagnosis of a miscarriage.
-
Four women have successfully had combined surgery at UCLH in which they gave birth by caesarean section and at the same time had surgery to reduce their risk of ovarian cancer.
-
This information is for patients who have fibroids. It contains information about what fibroids are, how they can affect you and what treatments are available.
-
The pelvic pain management service at UCLH was established in 2006 and our clinicians have a wealth of experience in managing women with abdominal and pelvic pain, and especially with those who have experienced complications following mesh implantation.
-
During winter, the cold weather can put people at higher risk of becoming unwell.
File results
-
FOI/2022/0539 - Pharmacological choices made for patients undergoing joint replacement surgery
-
FOI/2022/0557 - Patients treated with Visudyne (verteporfin)
-
FOI/2022/0563 - Ambulatory cardiac monitoring
-
FOI/2022/0544 - Wards/ departments that provide services to 0-17 year-olds
-
FOI/2022/0545 - Criteria used in determining acceptance of GP referrals for osteoporosis treatment, and for priorisation of osteoporosis appointments
-
FOI/2022/0546 - Metastatic Cholangiocarcinoma (CCA) or Acute myeloid leukaemia
-
FOI/2022/0548 - Biologic and biosimilar products within Rheumatology
-
FOI/2022/0549 - SACT (systemic anti-cancer therapy) /cervical cancer treatments
-
FOI/2022/0550 - Patients that have been treated for glioblastoma brain cancer
-
FOI/2022/0553 - Patients tested for non-small cell lung cancer biomarkers